.jpg)
Opinion: The new law that could stealthily transform biomedical innovation
Buried deep within the Inflation Reduction Act’s drug-price negotiation provisions is language that could open the way to a new era of biomedical breakthroughs and smarter health spending.
This language does something Medicare hasn’t tried before: It ties payment for treatments to how well they work. Doing so used to be illegal. But it will now be required for some drugs.
Read Original Article: Opinion: The new law that could stealthily transform biomedical innovation »
